Citigroup »

Fibrobiologics shares owned by Citigroup

Quarter-by-quarter ownership of Fibrobiologics shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $329k 30k 10.81

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Fibrobiologics

Millennium Management
Hrt Financial
Marshall Wace
Citigroup
ExodusPoint Capital Management
Jpmorgan Chase & Co
Goss Wealth Management
Point72
Balyasny Asset Management
BlackRock
Geode Capital Management
Cubist Systematic Strategies
Macquarie Group
Royal Bank of Canada
Hanson McClain Advisors

View all funds holding Fibrobiologics